HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lilianne Kim Selected Research

golimumab

9/2021The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial.
4/2021The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.
11/2020Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study.
10/2020Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial.
10/2020Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial.
1/2020Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis.
10/2019Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.
1/2019Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial.
1/2018Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
1/2018Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lilianne Kim Research Topics

Disease

6Psoriatic Arthritis
09/2021 - 11/2017
6Rheumatoid Arthritis
12/2015 - 04/2010
4Ankylosing Spondylitis
04/2021 - 01/2018
4Infections
11/2017 - 09/2008
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 11/2017
2Chronic Disease (Chronic Diseases)
10/2020 - 06/2014
2Fatigue
10/2020 - 06/2014
1Arthritis (Polyarthritis)
11/2020
1Opportunistic Infections (Opportunistic Infection)
01/2020
1Neoplasms (Cancer)
01/2020
1Injection Site Reaction
01/2018
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2018
1Necrosis
01/2018
1Pathologic Complete Response
09/2008
1Relapsing-Remitting Multiple Sclerosis
09/2008
1Multiple Sclerosis
09/2008

Drug/Important Bio-Agent (IBA)

17golimumabFDA Link
09/2021 - 04/2010
5Methotrexate (Mexate)FDA LinkGeneric
12/2015 - 12/2011
3ametantrone (HAQ)IBA
10/2020 - 06/2014
1AS 8IBA
09/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010
1GadoliniumIBA
09/2008
1Pharmaceutical PreparationsIBA
09/2008
1Monoclonal AntibodiesIBA
09/2008
1Ustekinumab (CNTO 1275)FDA Link
09/2008
1Interleukin-12 (IL 12)IBA
09/2008
1InterleukinsIBA
09/2008

Therapy/Procedure

6Therapeutics
10/2020 - 03/2013
1Injections
01/2018
1Intravenous Administration
04/2010
1Subcutaneous Injections
09/2008